Inventor · disambiguated record
S. David Brown
Also filed as: BROWN S DAVID
14 granted patents·4 pending applications·123 citations·filing 2002–2022
92Inventor score
Top patents by PatentIndex Score
18 records- 0196US7989622B2Phosphatidylinositol 3-kinase inhibitors and methods of their useEXELIXIS INC·Filed 2006·Granted Aug 2, 2011·64 cites·7 claims
- 0291US11400097B2(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesMEI PHARMA INC·Filed 2020·Granted Aug 2, 2022·2 cites·7 claims
- 0390US10335415B2(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesMEI PHARMA INC·Filed 2018·Granted Jul 2, 2019·6 cites·21 claims
- 0490US10064868B2(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesMEI PHARMA INC·Filed 2015·Granted Sep 4, 2018·7 cites·15 claims
- 0589US10603324B2(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesMEI PHARMA INC·Filed 2019·Granted Mar 31, 2020·5 cites·19 claims
- 0687US9056852B2(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesBROWN S DAVID·Filed 2012·Granted Jun 16, 2015·11 cites·109 claims
- 0783US12059422B2(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesMEI PHARMA INC·Filed 2022·Granted Aug 13, 2024·0 cites·9 claims
- 0883US8053454B2Pyridopyrimidinone inhibitors of PIM-1 and/or PIM-3EXELIXIS INC·Filed 2006·Granted Nov 8, 2011·4 cites·10 claims
- 0982US8242129B26-phenylpyrimidinones as PIM modulatorsTSUHAKO AMY L·Filed 2008·Granted Aug 14, 2012·8 cites·12 claims
- 1079US8440663B24-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as JAK-2 modulators and methods of useMANN GRACE·Filed 2007·Granted May 14, 2013·7 cites·33 claims
- 1172US8889664B2Phosphatidylinositol 3-kinase inhibitors and methods of their useBAJJALIEH WILLIAM·Filed 2011·Granted Nov 18, 2014·3 cites·10 claims
- 1267US8013156B2Tie-2 modulators and methods of useEXELIXIS INC·Filed 2004·Granted Sep 6, 2011·4 cites·26 claims
- 1364US7498358B2Human ADAM-10 inhibitorsEXELIXIS INC·Filed 2002·Granted Mar 3, 2009·2 cites·27 claims
- 1458US7951972B2Human adam-10 inhibitorsEXELIXIS INC·Filed 2009·Granted May 31, 2011·0 cites·19 claims
- 1549US2009247559A1BenzofuropyrimidinonesEXELIXIS INC·Filed 2008·Application pending·0 cites
- 1641US2014088102A1(alpha-substituted cycloalkylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesMEI PHARMA INC·Filed 2012·Application pending·0 cites
- 1737US2014088103A1(fused ring arylamino and heterocyclylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseasesBROWN S DAVID·Filed 2012·Application pending·0 cites
- 1834US2013165440A1JAK1 InhibitorsANAND NEEL KUMAR·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →